This encouraged scientists to begin investigating whether targeting the central nervous system could provide an effective strategy for weight loss (Capozzi, DiMarchi, Tschpp)
MAUD-Obesity Trial (n = 3,276): Alcohol-related hospitalization occurred in 10.2% of newer GLP-1 RA users and 28.5% of MAUD users
Lack of Medical Supervision GLP1 medications require a prescription and ongoing medical supervision to ensure safe and effective use
Some important factors to consider include allergic responses, injection site reactions, electrolyte imbalances, kidney and liver function, skin-lightening concerns, drug interactions, gastrointestinal disturbances, and long-term safety
Getting clear answers early can help you avoid unnecessary worry and take the right steps forward